IL28B polymorphisms do not predict response to therapy in chronic hepatitis C with HCV genotype 5

Nabil Antaki; Stéphanie Bibert; Kamel Kebbewar; Fouad Asaad; Osama Baroudi; Sawsan Alideeb; Milad Hadad; Dirar Abboud; Houda Sabah; Pierre-Yves Bochud; Francesco Negro

doi:10.1136/gutjnl-2012-302019

Article info

This article has a correction. Please see:

Simulation of macroamylasaemia by salivary-type (`S type') hyperamylasaemia - January 01, 1974

PostScript

Letters

IL28B polymorphisms do not predict response to therapy in chronic hepatitis C with HCV genotype 5

Authors

Nabil Antaki 1Department of Gastroenterology, Saint Louis Hospital, Ismailiye, Aleppo, Syria PubMed articles Google scholar articles
Stéphanie Bibert 2Service of Infectious Diseases, Department of Medicine, University Hospital and University of Lausanne, Lausanne, Switzerland PubMed articles Google scholar articles
Kamel Kebbewar 3Laboratory Medicine, Saint Louis Hospital, Ismailiye, Aleppo, Syria PubMed articles Google scholar articles
Fouad Asaad 4Department of Internal Medicine, Squelbiye National Hospital, Squelbiye, Syria PubMed articles Google scholar articles
Osama Baroudi 5Department of Gastroenterology, Damascus Hospital, Damascus, Syria PubMed articles Google scholar articles
Sawsan Alideeb 5Department of Gastroenterology, Damascus Hospital, Damascus, Syria PubMed articles Google scholar articles
Milad Hadad 6Department of Gastroenterology, Ibn Nafis Hospital, Damascus, Syria PubMed articles Google scholar articles
Dirar Abboud 1Department of Gastroenterology, Saint Louis Hospital, Ismailiye, Aleppo, Syria PubMed articles Google scholar articles
Houda Sabah 7Department of Laboratory Medicine, Damascus Hospital, Damascus, Syria PubMed articles Google scholar articles
Pierre-Yves Bochud 2Service of Infectious Diseases, Department of Medicine, University Hospital and University of Lausanne, Lausanne, Switzerland PubMed articles Google scholar articles
Francesco Negro 8Divisions of Gastroenterology and Hepatology and of Clinical Pathology, University Hospital, Genève, Switzerland PubMed articles Google scholar articles

Correspondence to Professor Francesco Negro, Divisions of Gastroenterology and Hepatology and of Clinical Pathology, University Hospitals, 4 rue Gabrielle-Perret-Gentil, CH-1211 Geneva 14, Switzerland; francesco.negro{at}hcuge.ch

View Full Text

Citation

Antaki N, Bibert S, Kebbewar K, et al

IL28B polymorphisms do not predict response to therapy in chronic hepatitis C with HCV genotype 5

Gut 2012;61:1640-1641.

Publication history

Accepted January 12, 2012
First published February 16, 2012.

Online issue publication

January 09, 2022

Article Versions

Previous version (18 April 2016).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions

Log in using your username and password

Main menu

Log in using your username and password

You are here

This article has a correction. Please see:

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password